CHARTWELL INVESTMENT PARTNERS, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2020$957,000
-0.5%
16,362
+36.3%
0.04%
+40.6%
Q4 2019$962,000
-44.9%
12,004
-49.5%
0.03%
-44.8%
Q3 2019$1,747,000
-22.1%
23,7750.0%0.06%
-20.5%
Q2 2019$2,243,000
+43.3%
23,775
+21.6%
0.07%
+43.1%
Q1 2019$1,565,00019,5560.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders